A Randomized, Placebo-Controlled, Double-Blind, Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of PRA-027 Administered Orally to Japanese Postmenopausal Women.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 09 Dec 2009
At a glance
- Drugs PRA 027 (Primary)
- Indications Menopausal syndrome
- Focus Adverse reactions
- 05 Mar 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 05 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2009 New trial record.